Selkirk Pharma has filed a notice of an exempt offering of securities to raise $25,000,002.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Selkirk Pharma is raising $25,000,002.00 in new funding. Sources indicate that as part of senior management President, Partick Haffey played a key role in securing…